无活检根治性前列腺切除术：考虑基本原理、局限性和当前数据的叙述性回顾

IF 2.7 2区医学 Q2 UROLOGY & NEPHROLOGY

Prostate International Pub Date : 2025-06-01 DOI:10.1016/j.prnil.2025.03.003

Arya Bahadori , Jessie Woods , Lance Yuan , Louise Emmett , John Yaxley , Matthew J. Roberts

{"title":"无活检根治性前列腺切除术：考虑基本原理、局限性和当前数据的叙述性回顾","authors":"Arya Bahadori , Jessie Woods , Lance Yuan , Louise Emmett , John Yaxley , Matthew J. Roberts","doi":"10.1016/j.prnil.2025.03.003","DOIUrl":null,"url":null,"abstract":"<div><div>Prostate biopsy prior to radical treatment for prostate cancer is a common practice worldwide to allow diagnosis, prognostication, and treatment planning. However, recent advances in prostate multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) have made the possibility of a “biopsy-free” radical prostatectomy, without prior biopsy, closer to reality than before. The biopsy-free approach serves to avoid investigation-related morbidity, health care resources, and time to definitive treatment, but is not without risk. Here we review the literature surrounding the rationale, limitations, and current data.</div></div>","PeriodicalId":20845,"journal":{"name":"Prostate International","volume":"13 2","pages":"Pages 67-73"},"PeriodicalIF":2.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data\",\"authors\":\"Arya Bahadori , Jessie Woods , Lance Yuan , Louise Emmett , John Yaxley , Matthew J. Roberts\",\"doi\":\"10.1016/j.prnil.2025.03.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Prostate biopsy prior to radical treatment for prostate cancer is a common practice worldwide to allow diagnosis, prognostication, and treatment planning. However, recent advances in prostate multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) have made the possibility of a “biopsy-free” radical prostatectomy, without prior biopsy, closer to reality than before. The biopsy-free approach serves to avoid investigation-related morbidity, health care resources, and time to definitive treatment, but is not without risk. Here we review the literature surrounding the rationale, limitations, and current data.</div></div>\",\"PeriodicalId\":20845,\"journal\":{\"name\":\"Prostate International\",\"volume\":\"13 2\",\"pages\":\"Pages 67-73\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Prostate International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2287888225000091\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Prostate International","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2287888225000091","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

前列腺癌根治性治疗前的前列腺活检是世界范围内的一种常见做法，可用于诊断、预测和制定治疗计划。然而，前列腺多参数磁共振成像（mpMRI）和前列腺特异性膜抗原(PSMA)-正电子发射断层扫描（PET）的最新进展使得无需事先活检的“无活检”根根性前列腺切除术比以前更接近现实。无活检方法有助于避免与调查相关的发病率、卫生保健资源和确定治疗的时间，但并非没有风险。在这里，我们回顾文献围绕的基本原理，局限性，和目前的数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Biopsy-free radical prostatectomy: a narrative review considering rationale, limitations, and current data

Prostate biopsy prior to radical treatment for prostate cancer is a common practice worldwide to allow diagnosis, prognostication, and treatment planning. However, recent advances in prostate multiparametric magnetic resonance imaging (mpMRI) and prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) have made the possibility of a “biopsy-free” radical prostatectomy, without prior biopsy, closer to reality than before. The biopsy-free approach serves to avoid investigation-related morbidity, health care resources, and time to definitive treatment, but is not without risk. Here we review the literature surrounding the rationale, limitations, and current data.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Prostate International Medicine-Urology

CiteScore

4.40

自引率

26.70%

发文量

审稿时长

35 days

期刊介绍： Prostate International (Prostate Int, PI), the official English-language journal of Asian Pacific Prostate Society (APPS), is an international peer-reviewed academic journal dedicated to basic and clinical studies on prostate cancer, benign prostatic hyperplasia, prostatitis, and ...